Clinical Trials Update: Oct. 7, 2002
Sepsis and Septicemia Depression (Treatment-Resistant) Diabetic Neuropathy
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch.
Sepsis and Septicemia
Research study to evaluate the efficacy and safety of Drotrecogin Alfa (Activated) in adult patients with Early Stage Severe Sepsis. To be included in this study you must: be an adult with severe sepsis, have presence of a suspected or proven infection and one or more instances of sepsis-associated organ failure. Sites throughout the world.
A research study to evaluate the efficacy and safety of an investigational drug in patients 18 to 85 years old with treatment-resistant depression. Sites throughout the USA.
Clinical trial for the treatment for Symptomatic Peripheral Neuropathy in patients with diabetes. The purpose of this study is to determine if an investigational drug is effective in treating nerve malfunction in diabetes. Sites throughout the world.
Copyright 2002 Centerwatch. All rights reserved.